Clinical decision-making in benzodiazepine deprescribing by healthcare providers vs. AI-assisted approach.

Journal: British journal of clinical pharmacology
PMID: 37949663

Abstract

AIMS: The aim of this study was to compare the clinical decision-making for benzodiazepine deprescribing between a healthcare provider (HCP) and an artificial intelligence (AI) chatbot GPT4 (ChatGPT-4).

Authors

  • Iva Bužančić
    Center for Applied Pharmacy, Faculty of Pharmacy and Biochemistry, University of Zagreb, Zagreb, Croatia.
  • Dora Belec
    Center for Applied Pharmacy, Faculty of Pharmacy and Biochemistry, University of Zagreb, Zagreb, Croatia.
  • Margita Držaić
    Center for Applied Pharmacy, Faculty of Pharmacy and Biochemistry, University of Zagreb, Zagreb, Croatia.
  • Ingrid Kummer
    Department of Social and Clinical Pharmacy, Faculty of Pharmacy in Hradec Králové, Charles University, Hradec Králové, Czech Republic.
  • Jovana Brkić
    Department of Social and Clinical Pharmacy, Faculty of Pharmacy in Hradec Králové, Charles University, Hradec Králové, Czech Republic.
  • Daniela Fialová
    Department of Social and Clinical Pharmacy, Faculty of Pharmacy, Charles University, Hradec Králové, Czech Republic.
  • Maja Ortner Hadžiabdić
    Center for Applied Pharmacy, Faculty of Pharmacy and Biochemistry, University of Zagreb, Zagreb, Croatia.

Keywords

External Resources

Popular Topics
Recent Journals